Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EZETIMIBE\SIMVASTATIN Cause Lung neoplasm malignant? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lung neoplasm malignant have been filed in association with EZETIMIBE\SIMVASTATIN. This represents 0.3% of all adverse event reports for EZETIMIBE\SIMVASTATIN.

6
Reports of Lung neoplasm malignant with EZETIMIBE\SIMVASTATIN
0.3%
of all EZETIMIBE\SIMVASTATIN reports
3
Deaths
3
Hospitalizations

How Dangerous Is Lung neoplasm malignant From EZETIMIBE\SIMVASTATIN?

Of the 6 reports, 3 (50.0%) resulted in death, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Lung neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\SIMVASTATIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does EZETIMIBE\SIMVASTATIN Cause?

Myalgia (244) Acute kidney injury (132) Rhabdomyolysis (113) Drug hypersensitivity (112) Arthralgia (89) Diarrhoea (71) Muscle spasms (70) No adverse event (68) Fatigue (66) Rash (54)

What Other Drugs Cause Lung neoplasm malignant?

RANITIDINE (15,214) ADALIMUMAB (698) TIOTROPIUM (637) ETANERCEPT (612) METHOTREXATE (522) CLOZAPINE (440) APIXABAN (411) ALBUTEROL (403) INFLIXIMAB (379) BUDESONIDE\FORMOTEROL (353)

Which EZETIMIBE\SIMVASTATIN Alternatives Have Lower Lung neoplasm malignant Risk?

EZETIMIBE\SIMVASTATIN vs EZOGABINE EZETIMIBE\SIMVASTATIN vs FACTOR XIII CONCENTRATE EZETIMIBE\SIMVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI EZETIMIBE\SIMVASTATIN vs FAMCICLOVIR EZETIMIBE\SIMVASTATIN vs FAMOTIDINE

Related Pages

EZETIMIBE\SIMVASTATIN Full Profile All Lung neoplasm malignant Reports All Drugs Causing Lung neoplasm malignant EZETIMIBE\SIMVASTATIN Demographics